These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10230183)

  • 21. Pharmacotherapy of childhood obsessive-compulsive disorder.
    Leonard HL; Rapoport JL
    Psychiatr Clin North Am; 1989 Dec; 12(4):963-70. PubMed ID: 2690035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
    Mathet F; Martin-Guehl C; Maurice-Tison S; Bouvard MP
    Encephale; 2003; 29(5):391-400. PubMed ID: 14615688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paroxetine treatment of mood and anxiety disorders in children and adolescents.
    Wagner KD
    Psychopharmacol Bull; 2003; 37 Suppl 1():167-75. PubMed ID: 14566209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent developments in the use of antidepressant and anxiolytic medications.
    Simeon JG; Ferguson HB
    Psychiatr Clin North Am; 1985 Dec; 8(4):893-907. PubMed ID: 2867535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mood stabilizers in children and adolescents.
    Ryan ND; Bhatara VS; Perel JM
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):529-36. PubMed ID: 10230184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of antidepressant medications in children and adolescents with non-obsessive-compulsive disorder anxiety disorders: a systematic assessment.
    Gentile S
    Expert Opin Drug Saf; 2014 Jun; 13(6):735-44. PubMed ID: 24845944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective serotonin re-uptake inhibitors for children and adolescents.
    Ziervogel CF
    Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I20-6. PubMed ID: 11140777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressant treatment in children and adolescents: bridging the gap between efficacy and effectiveness.
    Zito JM; Safer DJ
    Curr Psychiatry Rep; 2001 Apr; 3(2):115-25. PubMed ID: 11276406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological treatment of depression in children and adolescents.
    Findling RL; Reed MD; Blumer JL
    Paediatr Drugs; 1999; 1(3):161-82. PubMed ID: 10937449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Timely topics in pediatric psychiatry.
    Dineen Wagner K
    J Clin Psychiatry; 2014 Nov; 75(11):1224-5. PubMed ID: 25470084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressant Efficacy for Depression in Children and Adolescents: Industry- and NIMH-Funded Studies.
    Walkup JT
    Am J Psychiatry; 2017 May; 174(5):430-437. PubMed ID: 28253735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prescribing Pattern of Antidepressants in Children and Adolescents: Findings from the Research on Asia Psychotropic Prescription Pattern.
    Chee KY; Tripathi A; Avasthi A; Chong MY; Xiang YT; Sim K; Kanba S; He YL; Lee MS; Chiu HF; Yang SY; Kuga H; Udomratn P; Tanra AJ; Maramis MM; Grover S; Mahendran R; Kallivayalil RA; Shen WW; Shinfuku N; Tan CH; Sartorius N
    East Asian Arch Psychiatry; 2016 Mar; 26(1):10-7. PubMed ID: 27086755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressant treatments in children and adolescents. I. Affective disorders.
    Ambrosini PJ; Bianchi MD; Rabinovich H; Elia J
    J Am Acad Child Adolesc Psychiatry; 1993 Jan; 32(1):1-6. PubMed ID: 8428861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review of the efficacy and safety of antidepressants in youth depression.
    Cheung AH; Emslie GJ; Mayes TL
    J Child Psychol Psychiatry; 2005 Jul; 46(7):735-54. PubMed ID: 15972068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benefits and risks of using antidepressants in children and adolescents.
    Bailly D
    Expert Opin Drug Saf; 2008 Jan; 7(1):9-27. PubMed ID: 18171311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychopharmacology of depression in children and adolescents.
    Smiga SM; Elliott GR
    Pediatr Clin North Am; 2011 Feb; 58(1):155-71, xi. PubMed ID: 21281854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence-based treatments in child and adolescent psychiatry: an inventory.
    McClellan JM; Werry JS
    J Am Acad Child Adolesc Psychiatry; 2003 Dec; 42(12):1388-400. PubMed ID: 14627873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressant treatments in children and adolescents: II. Anxiety, physical, and behavioral disorders.
    Ambrosini PJ; Bianchi MD; Rabinovich H; Elia J
    J Am Acad Child Adolesc Psychiatry; 1993 May; 32(3):483-93. PubMed ID: 8496110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescription Pattern of Antidepressants for Children and Adolescents in Korea Based on Nationwide Data.
    Chon MW; Lee J; Chung S; Kim Y; Kim HW
    J Korean Med Sci; 2017 Oct; 32(10):1694-1701. PubMed ID: 28875616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A risk-benefit assessment of pharmacotherapies for clinical depression in children and adolescents.
    Renaud J; Axelson D; Birmaher B
    Drug Saf; 1999 Jan; 20(1):59-75. PubMed ID: 9935277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.